Latest Revenue Model News

Transurban showcased the West Gate Tunnel’s technology and benefits as April traffic data revealed growth in Melbourne and Brisbane but a dip in Sydney. Commercial vehicle volumes surged, while North American toll prices climbed sharply in the March quarter.

OpenLearning accelerated its SaaS annual recurring revenue by 35% year-on-year to $3.192 million in Q1 FY26, propelled by larger multi-year LMS contracts and ongoing AI platform enhancements.

Swift TV has rapidly deployed over 2,700 screens across multiple enterprise sites, marking its transition from development to revenue-generating commercial rollout backed by multi-year contracts and a fresh 5,000-unit order.

CONNEQT Health’s Pulse device sales surged to a $7 million annualised run-rate despite a temporary supply hiccup, while the company manages a tight cash runway supported by new R&D loans and related-party funding.

Stakk Ltd has reported a striking 186% quarter-on-quarter revenue jump to A$5.52 million in Q1 2026, driven by converting contracted clients into active billing and new engagements, underpinning strong recurring revenue and cash flow.

Klevo Rewards has made major strides in Q1 2026, unveiling an Australian dollar-backed stablecoin and securing SWIFT network access through Fly Wallet, boosting its global payments and rewards platform.

De.mem Limited has extended its growth streak with record quarterly cash receipts of approximately $10.4 million, a 31% increase year-on-year, alongside positive operating cash flow of $504,000 for the March 2026 quarter.

InteliCare has inked a $200,000 contract to deploy its AI-powered monitoring platform across 65 retirement villas at Warrigal's new development, marking its first foray into the retirement living sector with potential for wider rollout.

NoviqTech’s Coralia has teamed with Swinburne University to explore biochar’s role in reducing embodied carbon in concrete, targeting the booming data centre construction sector.

Advanced Braking Technology Ltd (ASX: ABV) reported a 28% jump in product sales revenue to $6 million for Q3 FY26, driven by strong aftermarket sales and international market traction. The company also advanced certification of its autonomous BRAKEiQ system, targeting FY27 adoption.

Emyria has unveiled the Empax Global Partnership Program, a high-margin clinical delivery platform targeting international drug sponsors amid growing demand for psychedelic-assisted mental health treatments.

Memphasys Limited has marked a milestone quarter with revenue surpassing A$100,000, driven by repeat orders and multi-year contracts, signalling its transition to a commercially focused biotech business.